Neumora Therapeutics NMRA
NASDAQ NMRA
$0.47 +0.01 (+1.37%)
At close: Nov 11, 2026 · 4:00 PM EST

Neumora Therapeutics (NMRA) Invested Capital (2024 - 2026)

Updated

Neumora Therapeutics (NMRA) reported Invested Capital of $97.43 million for Q2 2026, down 51.8% from $202.33 million a year earlier and down 21.2% from the prior quarter.

Analysis

Neumora Therapeutics (NMRA) Invested Capital (2024 - 2026) Analysis & Trends

For FY2025, Neumora Therapeutics posted Invested Capital of $158.4 million, down 44.8% from FY2024.

  • By year, Invested Capital came in at $287.06 million in FY2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $123.64 million (Q1 2026), $158.4 million (Q4 2025) and $151.72 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 89.77 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 126.18 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 76.32 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 98.72 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 45.14 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 68.36 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 39.27 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 151.97 Bn
10 Neumora Therapeutics 88.31 Mn -529.65 Mn - 97.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 97.43 Mn
Mar 31, 2026 123.64 Mn
Dec 31, 2025 158.40 Mn
Sep 30, 2025 187.04 Mn
Jun 30, 2025 202.33 Mn
Dec 31, 2024 287.06 Mn
API Access

Neumora Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=NMRA&period=max&api_key=YOUR_API_KEY